Status epilepticus: a critical review (Q37399583)

20 August 2017

1 reference

title

Status epilepticus: a critical review (English)

1 reference

20 August 2017

1 reference

3

Felix Rosenow

1 reference

20 August 2017

1

Susanne Knake

1 reference

20 August 2017

2

Hajo M Hamer

1 reference

20 August 2017

publication date

21 February 2009

1 reference

20 August 2017

1 reference

20 August 2017

volume

15

1 reference

20 August 2017

issue

1

1 reference

20 August 2017

page(s)

10-14

1 reference

Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Incidence of status epilepticus in French-speaking Switzerland: (EPISTAR).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Incidence of status epilepticus in Rochester, Minnesota, 1965-1984.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Incidence and case-fatality rate of status epilepticus in the Canton of Geneva

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Incidence of status epilepticus in adults in Germany: a prospective, population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Epidemiology of status epilepticus in a rural area of northern Italy: a 2-year population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Incidence and short-term prognosis of status epilepticus in adults in Bologna, Italy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: prospective population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Status epilepticus after stroke is associated with increased long-term case fatality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Status epilepticus: risk factors and complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Mortality after a first episode of status epilepticus in the United States and Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

7 January 2021

Mortality in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

The epidemiology of convulsive and nonconvulsive status epilepticus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Incidence and mortality of generalized convulsive status epilepticus in California

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Status epilepticus at an urban public hospital in the 1980s

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Analysis of clinical characteristics and risk factors for mortality in human status epilepticus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Status epilepticus treatment guidelines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

EFNS guideline on the management of status epilepticus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Treatment of status epilepticus in adults: guidelines of the Italian League against Epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Out-of-hospital treatment of status epilepticus and prolonged seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

The prehospital treatment of status epilepticus (PHTSE) study: design and methodology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

A comparison of rectal diazepam gel and placebo for acute repetitive seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Nasal benzodiazepines for management of acute childhood seizures?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Comparison of intranasal midazolam with intravenous diazepam for treating acute seizures in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Pharmacokinetics and pharmacodynamics of midazolam administered as a concentrated intranasal spray. A study in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Pharmacokinetic optimization of benzodiazepine therapy for acute seizures. Focus on delivery routes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Intranasal midazolam therapy for pediatric status epilepticus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Anticonvulsant therapy for status epilepticus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Propranolol and infarct size

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Extravasation injury to the hand by intravenous phenytoin. Report of three cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

A prospective study of the incidence of the purple glove syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Incidence and clinical consequence of the purple glove syndrome in patients receiving intravenous phenytoin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Venous irritation related to intravenous administration of phenytoin versus fosphenytoin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Pharmacology and pharmacokinetics of fosphenytoin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Phenytoin penetration into brain after administration of phenytoin or fosphenytoin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Refractory status epilepticus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Refractory status epilepticus in 2001.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Treatment of refractory status epilepticus: literature review and a proposed protocol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Relapse and survival after barbiturate anesthetic treatment of refractory status epilepticus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Treatment of refractory status epilepticus with propofol: clinical and pharmacokinetic findings.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Prognostic factors of pentobarbital therapy for refractory generalized status epilepticus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Refractory status epilepticus: frequency, risk factors, and impact on outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Refractory status epilepticus: effect of treatment aggressiveness on prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Treatment of refractory status epilepticus with inhalational anesthetic agents isoflurane and desflurane

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Which anesthetic should be used in the treatment of refractory status epilepticus?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Refractory status epilepticus: response to ketamine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Sodium valproate vs phenytoin in status epilepticus: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Safety of rapid intravenous infusion of valproate loading doses in epilepsy patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Intravenous valproate in pediatric epilepsy patients with refractory status epilepticus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Intravenous valproate is well tolerated in unstable patients with status epilepticus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Efficacy of rapid IV administration of valproic acid for status epilepticus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Valproate is an effective, well-tolerated drug for treatment of status epilepticus/serial attacks in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Non convulsive status epilepticus after replacement of valproate with lamotrigine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Acute encephalopathy after intravenous administration of valproate in non-convulsive status epilepticus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Non-convulsive status epilepticus secondary to valproic acid-induced hyperammonemic encephalopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Homozygous W748S mutation in the POLG1 gene in patients with juvenile-onset Alpers syndrome and status epilepticus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Termination of complex partial status epilepticus by intravenous levetiracetam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Intravenous levetiracetam in the treatment of benzodiazepine refractory status epilepticus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

Intravenous lacosamide as replacement for oral lacosamide in patients with partial-onset seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.02.027

10.1016/J.YEBEH.2009.02.027

7 January 2021

Identifiers

DOI

1 reference

20 August 2017

1 reference